Table 1.
Gene Set | NESa | p value | FDRb |
---|---|---|---|
Bile acid metabolism | 2.32 | <0.001 | <0.001 |
Coagulation | 2.25 | <0.001 | <0.001 |
Xenobiotic metabolism | 2.20 | <0.001 | <0.001 |
Fatty acid metabolism | 2.20 | <0.001 | <0.001 |
Heme metabolism | 2.04 | <0.001 | <0.001 |
Adipogenesis | 1.91 | <0.001 | <0.001 |
Peroxisome | 1.90 | <0.001 | <0.001 |
Interferon alpha response | 1.90 | <0.001 | <0.001 |
Oxidative phosphorylation | 1.90 | <0.001 | <0.001 |
Estrogen response late | 1.89 | <0.001 | <0.001 |
Angiogenesis | 1.72 | 0.002 | 0.003 |
Cholesterol homeostasis | 1.68 | 0.004 | 0.005 |
Hypoxia | 1.61 | <0.001 | 0.010 |
Interferon gamma response | 1.60 | <0.001 | 0.009 |
Reactive oxygen species pathway | 1.59 | 0.013 | 0.010 |
Estrogen response early | 1.58 | <0.001 | 0.011 |
Myogenesis | 1.57 | 0.002 | 0.012 |
IL2 STAT5 signaling | 1.54 | <0.001 | 0.013 |
IL6 JAK STAT3 signaling | 1.54 | 0.008 | 0.014 |
Complement | 1.49 | 0.003 | 0.021 |
MTORC1 signaling | −1.50 | 0.005 | 0.012 |
Unfolded protein response | −1.82 | <0.001 | <0.001 |
G2M checkpoint | −2.01 | <0.001 | <0.001 |
E2F targets | −2.02 | <0.001 | <0.001 |
MYC targets V2 | −2.54 | <0.001 | <0.001 |
MYC targets V1 | −2.64 | <0.001 | <0.001 |
Normalized enrichment score.
False discovery rate.